OpenLegislation

Division 4

United Kingdom

Original text. Later amendments are not shown.

The IIFT is a rapid technique with high sensitivity and specificity for the detection of ASF antibodies from either sera or tissue exudates. It is based on the detection of ASF antibodies that bind to a monolayer of MS cells infected with an adapted ASF virus. The antibody-antigen reaction is detected by a labelled fluorescein A-protein. Positive samples show specific fluorescence near the nucleus of the infected cells.

DIFT and IIFT used in combination to test organ, blood and exudates collected from animals showing clinical signs of the ASF may lead to a rapid and reliable confirmation of the disease.

Notes on Chapter VII

Textual amendments

F1

Words in Annex Ch. 7 s. B omitted (31.12.2020) by virtue of The Exotic Disease (Amendment etc.) (EU Exit) Regulations 2018 (S.I. 2018/1410), regs. 1, 8(8)(a); 2020 c. 1, Sch. 5 para. 1(1)

F2

Words in Annex Ch. 7 s. B substituted (31.12.2020) by The Exotic Disease (Amendment etc.) (EU Exit) Regulations 2018 (S.I. 2018/1410), regs. 1, 8(8)(b); 2020 c. 1, Sch. 5 para. 1(1)